Sunday 19 October 2014

GSK says Ebola vaccine development progressing at "unprecedented rate"

A British Airways airplane flies past a signage for pharmaceutical giant GlaxoSmithKlein in London LONDON (Reuters) - Britain's biggest drugmaker GlaxoSmithKline said on Saturday work to develop a vaccine to combat Ebola, which has killed thousands in West Africa, was moving at a rapid pace. "Development of the vaccine candidate is progressing at an unprecedented rate, with first phase 1 safety trials with the vaccine candidate underway in the USA, UK and Mali, and further trials due to start in the coming weeks," the firm said in a statement posted on its website. ...




via Health News Headlines - Yahoo News Read More Here..

No comments:

Post a Comment